BAYER AKTIENGESELLSCHAFT
- Country
- Germany
- Type
- Beneficiary
- Website
- www.bayerpharma.de
- Grants received
- 79
Funding record
- 79 grants on record
- €5,189,072.33 awarded in total
- 2015–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
56 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- JANSSEN PHARMACEUTICA NV
- ASTRAZENECA AB
- NOVARTIS PHARMA AG
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- ABBVIE INC
- MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
- BOEHRINGER INGELHEIM INTERNATIONALGMBH
- ELI LILLY AND COMPANY LTD
Calls from this organisation
No published calls from this organisation.
Grants received
- Molecularly Designed Polymers for Sustainable Agriculture
- Driving Sustainable Innovation to Minimise PFAS in European Healthcare
- FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
- Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG
- Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
- Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- Beyond neuroInflammation: new Concepts to Elucidate the immune system’s vital role in Parkinson’s disease
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Light-driven Catalytic Processes for the Stereoselective Functionalisation of C(sp3)-H Bonds
- Sharing and re-using clinical trial data to maximise impact
- Food Safety for Africa
- INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE
- Explainable AI for Molecules - AiChemist
- a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.